These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA. JAMA; 2002 Oct 09; 288(14):1749-57. PubMed ID: 12365959 [Abstract] [Full Text] [Related]
15. HPV testing is not useful for LSIL Triage--but stay tuned. Stoler MH. Adv Anat Pathol; 2001 May 01; 8(3):160-4. PubMed ID: 11345239 [No Abstract] [Full Text] [Related]
16. [Clinicopathological analysis of atypical endocervical cells in cervical cytology]. Zhong PP, Tian C, He Y, Chen TB, Mo N, Wang ZQ, Luo DY, Jin YL. Zhonghua Bing Li Xue Za Zhi; 2024 Jul 08; 53(7):728-730. PubMed ID: 38955706 [Abstract] [Full Text] [Related]
17. Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings. Cox JT. JAMA; 1999 May 05; 281(17):1645-7. PubMed ID: 10235161 [No Abstract] [Full Text] [Related]
18. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer. Costa S, Sideri M, Syrjänen K, Terzano P, De Nuzzo M, De Simone P, Cristiani P, Finarelli AC, Bovicelli A, Zamparelli A, Bovicelli L. Acta Cytol; 2000 May 05; 44(3):310-8. PubMed ID: 10833984 [Abstract] [Full Text] [Related]